Circadian rhythm in glomerular transport of macromolecules through large pores and shunt pathway  by Koopman, Marion G. et al.
Kidney International, Vol. 49 (1996), pp. 1242—1249
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Circadian rhythm in glomerular transport of macromolecules through
large pores and shunt pathway. In previous studies we have demonstrated
that the circadian rhythm in renal clearance of serum proteins is more
pronounced than the variability in glomerular filtration rate, and that the
highest day-night fluctuations are found for the largest proteins. To
analyze whether additional circadian rhythmicity in size-selective glomer-
ular transport could explain these phenomena, we measured renal clear-
ances of inulin and dextrans in a range of 30 to 90 A over a period of one
day and compared these data with renal clearance in proteins. Eight
patients with nephrotic syndrome and a GFR > 60 mI/mm and 6 healthy
volunteers were studied during a protocol of bed rest and spaced protein
and fluid intake. After administration of a loading dose, inulin and dextran
were continuously infused. Blood and urine were sampled every three
hours. In patients, but not in normals, fractional clearances of dextrans
larger than 45 A showed a circadian rhythm with a peak in daytime and a
close phase-relationship with the rhythm in GFR. The day-night differ-
ences were the most pronounced for the largest dextrans. Analysis of the
day-night differences in a computer model showed circadian variability in
transport through the shunt pathway and through large pores. These
results can, to an important degree, explain our previous observations
on circadian variability in renal clearance of proteins in patients with
nephrotic syndrome.
Urinary excretion of serum proteins follows a circadian rhythm,
with a maximum in daytime both in normal individuals [1] and in
patients with glomerular proteinuria [2—41. In patients with a
nephrotic syndrome day-night differences in excretion are the
more pronounced, the larger the size of the protein [3]. The most
selective proteinuria is produced during the night [2, 3]. The
mechanism of circadian variation in protein excretion and in
selectivity of proteinuria are still unknown.
Theoretically, a circadian rhythm in the renal clearance of a
serum protein can be determined by circadian variation in its
glomerular filtration and/or in its (fractional) tubular reabsorp-
tion. To produce fluctuations with 24 hour periodicity in these
processes, one has to assume dynamic functional changes, that is,
changes that are easily inducible and also easily reversible. In
previous studies we demonstrated that glomerular filtration rate,
effective renal plasma flow and filtration fraction follow circadian
rhythms both in healthy individuals [1, 5] and in patients with
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nephrotic syndrome [4, 51. In all normals and in many patients
the peak (orthophase) of these rhythms occurs in daytime. The
relative amplitudes of the rhythms in GFR and ERPF range
between 10 and 45% (on the average 25 to 30%). A circadian
rhythm in GFR implies that either the ultrafiltration coefficient
(Kf) or the filtration pressure (represented in the transcapillary
hydraulic pressure difference or P), or both, will fluctuate in
time.
The circadian rhythms in albuminuria in normals and in excre-
tion of several serum proteins in proteinuric patients [4] usually
are in phase with the rhythm in GFR but have much higher
relative amplitudes. These findings suggest that rhythmic variabil-
ity in GFR, that is, in Kf and/or zP, probably acts as the inductor
of the circadian rhythm in renal clearance of proteins, but that
circadian variability in either restriction of glomerular transport
or in fractional tubular reabsorption [1, 6], or both, must contrib-
ute as well.
The aim of the present study was to determine whether
size-selective restriction of glomerular transport of macromole-
cules has a circadian rhythm. If such a rhythm exists, and if the
amplitude of this rhythm indeed increases with the size of the
filtered macromolecule, it would explain the previously found
relationship between the size of a protein and the amplitude of its
rhythm in clearance.
For our study of circadian variations in size-dependent perm-
selectivity of the glomerular membrane, we administered neutral
dextran infusions to normal individuals and patients with glomer-
ular disease. Dextrans are suitable macromolecules for this pur-
pose because they are only filtered in the glomerulus and not
reabsorbed or secreted by the tubuli. By determining fractional
clearances of dextrans with increasing radius at different times of
the day, we were able to analyze possible circadian variations in
size-selective properties of the glomerular capillary wall, that is, in
participation of large pores and shunt pathway [7] in the glomer-
ular filtration of macromolecules.
Methods
Subjects and patients
Eight selected patients with glomerular disease were studied;
they had a nephrotic syndrome with a mild to moderate amount of
edema and a GFR above 60 mi/mm. Clinical data and morpho-
logical diagnosis are listed in Table 1. Six healthy volunteers
served as a control group. Informed consent was obtained in all
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Table 1. Clinical data of patients and normal subjects
Mean
Sex Age Proteinuria GFR
M/F years Diagnosis g/24 hr mi/mm ST.
Patient no.
M 19 MC 11.4 96 0.054
2 M 34 MC 5.8 62 0.098
3 M 24 MN 6.6 152 0.099
4 F 31 MN 2.8 95 0.100
5 M 22 MN 9.0 105 0.138
6 F 32 MN 5.1 116 0.141
7 M 45 FGS 16.6 75 0.261
8 M 30 MCGN 14.6 67 0.310
Normal 3M/3F 19—35 — 2.1-7.4 )< 10 98—131
subjects
Abbreviations are: MCGN, mesangiocapillary glomerulonephritis; MN,
membranous nephropathy; MC, minimal change nephropathy; FGS, focal
glomerulosclerosis; SI., selectivity index (IgG clearance/transferrin clear-
ance).
subjects. The study was approved by the Committee of Medical
Ethics of the University of Amsterdam.
Procedure
All subjects were admitted to the metabolic ward of the hospital
and kept strictly in bed. During the night (23.00 hr to 08.00 hr)
they were allowed to sleep between sampling and mealtimes. The
fluid intake was at least 300 ml per three hours to guarantee
sufficient urine production. The normal volunteers received meals
and drinks of identical composition every three hours. The protein
intake of the patients was kept as constant as possible during the
study. To achieve this a dietician divided the intake over the
drinks and five meals (at 18.00 hr, 24.00 hr, 06.00 hr, 12.00 hr and
18.00 hr).
The study started at 17.00 hours. At this time a cannula for
intravenous infusion was inserted in one arm and a sampling
device in the other. Loading doses of 60 mg/kg inulin (InutestR;
Laevosan Gesellschaft, Linz, Austria) and 7.5 mg/kg PAH (Ami-
nohippurate Sodium; Merck, Sharp and Dohme, Haarlem, the
Netherlands) were administered and this was followed by contin-
uous infusion to achieve serum concentrations of approximately
400 mg/liter for inulin and 20 mg/liter for PAH. A loading dose of
70 mg/kg of polydisperse Dextran 70 (MacrodexR; NPBI, Emmer-
compascuum, The Netherlands) was administered as well, fol-
lowed by a continuous infusion of polydisperse Dextran 40
(RheomacrodexR; NPBT) to maintain the serum concentrations of
the various dextrans as constant as possible during the entire
study. The infusion rate of dextran 40 was estimated on basis of
the creatinine clearance and ranged from 250 to 450 mg/hr. Prior
to the administration of Dextran 70 and 40, all subjects were given
20 ml of Dextran 1 (PromitenR; NPBI) intravenously to prevent
anaphylactic reactions. For the continuous infusion of inulin,
PAH and Dextran 40 volumetric infusion pumps were used
(IMED-micro 965 and a volumetric pump of Dascon By; Uden,
The Netherlands).
After an equilibration period of four hours, collections started
at 21.00 hours till 21.00 hours the next day. Every three hours
urine was collected by spontaneous voiding and blood samples
were taken. In all urine and blood aliquots the following solutes
were determined: inulin, PAH, albumin, transferrin (patients),
IgG (patients), n2-macroglobulin (patients) and dextran fractions.
Total protein was only determined in the blood samples. For all
these solutes clearances (standard method) and fractional clear-
ances were calculated. The fractional clearance of a solute is its
clearance expressed as percentage (or ratio) of the inulin clear-
ance (GFR).
Laboratory methods
Separation according to molecular radius and determination
of dextran fractions (30 A to 90 A) were done with gel permeation
chromatography and refraction index (RI.) detection. The col-
umns contained hydroxylated polyether based material, which is
especially useful for chromatography of neutral polymers. The
guard column was a TSK 40 XL column (75 mm X 7.5 mm, 1.D.)
and the analytical column a Bio Gel TSK 40 XL column (300 mm
X 7.5 mm, ID.), both from BioRad Chemical Division (Rich-
mond, VA, USA).
The columns were incorporated in an automated HPLC system
containing one HPLC spectroflow 400 pump and a spectroflow
450 controller, both from ABI Kratos Analytical (Ramsey, NJ,
USA), a PROMIS sample processor from Spark Holland
(Emmen, The Netherlands), an ERMA 7510 R.I. detector
(ERMA, Tokyo, Japan) and an SP 4290 integrator (Spectra
Physics, Eindhoven, The Netherlands). The latter was used in the
data "slice" mode, to calculate areas in slices of 12 seconds. A
fraction was defined as the area under the concentration curve for
12 seconds. The eluent was phosphate buffered saline: NaCI (0.14
mmol/liter), phosphate (0.01 mmol/liter), NaN3 (1 g/liter), pH 7.4.
The eluent flow was set at 0,50 mi/mm. The injection volume was
100 microliters for all samples. The column was calibrated with 6
narrow-cut dextran fractions with a molecular weight range of
10,000 to 130,000 (kindly provided by NPBI, Amsterdam, the
Netherlands). The molecular weights of the peak maxima were
converted to the molecular radius according to Granath and Kvist
(8]. Urine and serum samples were deproteinized with trichloro-
acetic acid. After centrifugation a further rinsing procedure was
established by gel permeation over a prepacked sephadex 25
column (PD 10 columns; Pharmacia, Uppsala, Sweden) to remove
residual low-molecular-weight proteins and peptides. Dextran
determinations in blood and urine for the fractions of 30 A to 90
A had a coefficient of variation of less than 10%. All samples were
analyzed in duplicate.
Albumin, transferrin and IgG in patients were analyzed with an
immunoturbidimetric method, albumin in the urine of normal
subjects with a nephelometric assay, alpha2-macroglobulin was
determined by an ELISA, total protein in serum by a biuret
reaction. Inulin was measured with the resorcinol method [9],
PAH with an HPLC-technique [10].
Analysis of circadian rhythms
Individual clearances and fractional clearances during a period
of 24 hours were analyzed for the presence of a circadian rhythm
by the cosinor method [1, 11]. Clearances and fractional clear-
ances per three hours were also converted to percentages of the
mean clearance or fractional clearance, and then averaged to
calculate the mean clearance or fractional clearance for each
three hour period for the whole group of patients or normals.
The orthophase of the rhythm is the time of the peak or
maximum clearance/fractional clearance of the day, the relative
amplitude of a rhythm is the amplitude (maximum minus mini-
mum clearance or fractional clearance) expressed as percentage
of the mean clearance or fractional clearance of the day: AIMX
100%. Daytime was defined as 8.00 to 23.00 hours, night as
23.00-8.00 hours. Differences were calculated with a Student's
t-test for paired data.
Analysis of day-night differences in glomerular membrane
properlies
To analyze circadian variations in the size-selective character-
istics of the glomerular barrier, wc used a computer program
based on a "two pores plus shunt pathway" model. This model was
chosen because it fits our data more satisfactorily, especially with
regard to the clearances of the larger dextrans in patients, than the
"one pore plus shunt" model of Deen et a! [7]. A computer model
for a log normal distribution of pores [12, 13] was not at our
disposal.
In normal subjects we used a P (transmembrane hydraulic
pressure difference) of 35 mm Hg [14, 15] and a renal plasma flow
(RPF) and filtration fraction (FF), based on an extraction of PAH
of 85% similar to that done in other groups [14, 15]. The K.
(product of effective hydraulic permeability and total glomerular
capillary surface area) in the normals during the daytime period
was then calculated as 14.91 4.31 mI/mm/mm Hg (Table 2),
which is in accordance with the literature [14, 15]. The most
accurate fit for the data in the normals was made when we used a
model of "two pores without an additional shunt." The smallest
error in the computer calculated line compared with the line
through the experimental data (SSE) was obtained when we
assumed that a small type of pore (r1) with a radius of 46 A was
present, and that about 5% of the filtration surface consisted of a
large type of pore (r2) with a size of 75 A (Table 3). Computer fits
in normals, based on the "one pore plus shunt" model, showed a
much larger error per data point (SSE/pp; P < 0.01), than the
"two pores without a shunt" model.
To make computer fits in the patients with nephrotic syndrome
we used a daytime P of 40 mm Hg. RPF and FF were calculated
choosing an extraction of PAH of 85% in the patients with normal
and of 70% in the patients with impaired renal function. These
values for P and extraction of PAH were also used in other
studies [14, 15]. To calculate oncotic pressure we used the mean
serum total protein concentration during the analyzed clearance
period. The data of the patients fit much better in a "two pores
plus shunt" than in a "two pores without a shunt" model. To be
able to compare data between patients and normals we fixed the
size of the large pore (r2) at 75 A and subsequently calculated the
best fit by varying the percentage filtration surface, occupied by r2,
the percentage of filtrate, passing through the shunt pathway (ü)
and the size of r1. The results obtained for these variables
appeared to be not much different when we used a P of 35 mm
Hg instead of 40 mm Hg, or when we used an extraction of PAH
of 85% instead of 70% (or vice versa). Only the K1 changed and
the error of the fit (SSE/pp) became larger.
To calculate differences between normals and patients we used
Student's t-test for unpaired data. To analyze day-night differ-
ences in membrane characteristics, we compared in each subject
the three-hour clearance period during the day at the peak of
GFR with the three hours clearance period during the night, at
the nadir (minimum) of GFR. Extraction of PAH was assumed to
be similar in the day and night periods. As we measured signifi-
cant differences between GFR and RPF and/or FF between day
and night (Table 2), there had to be a day-night difference either
in Kf or in P or in both (Table 2). Minor circadian variation in
serum protein concentration, and thus probably in oncotic pres-
sure, was only present in the normals, hut not in the patients. The
smallest SSE/pp were found when we let iç vary between day and
night and kept P constant. Day-night variations in membrane
characteristics were similar in both conditions. Differences be-
tween day and night were calculated using Student's t-test for
paired data.
Results
Normals
Fractional clearances of dextrans and proteins, averaged for the
whole period of 24 hours, are shown in Figure 1. The fractional
clearance of dextrans smaller than 43 A was higher 1P < 0.05),
and the fractional clearance of the dextran fractions with a larger
1244 Koopman Cl a!: Circadian rhythm in macromolecular transport
Table 2. Mean (± 5EM) day and night values for renal hemodynamic parameters
Normals MC MN FGSIMCGN All patientsN=6 N=2 N=4 N=2 N=8
Day
GFR mI/mm 132 10 81 125 72 101 10
RPF mI/mm 843 58 1050 1103 629 971 91
FF 0.16 0.01 0.08 0.11 0.11 0.11 001b
K1 mi/mm/mm Hg; P 40 3.04 4.69 3.02 3.90 0.42
K1 mi/mm/mm Hg; P 35 14.91 L76 3.76 5.83 3.83 4.84 0.44'
Night
GFR mI/mm 99 6' 73 95 51 78 8"
RPF mI/mm 822 64 859 763 445 707 80
FF 0.12 0.01' 0.13 0.09 0.12 0.12 0.01
Kf mi/mm/mm Hg; zP 40 2.83 3.82 1.91 3.08 Q35a
K1 mi/mm/mm Fig; 1P 35 8.38 0.80"
mm Hg; Kf constant at daytime value 30.4 1.8' 37.8 36.1 31.7 35.2 1.9"
Abbreviations are: MC, minimal change nephropathy; MN, membranous nephropathy; FGS, focal glomerular sclerosis; MCGN, mesangiocapillary
proliferative glomeru!onephritis.
'P < 0.01, night versus day
h P < 0.02, patients versus normals
CP < 0.01, patients versus normals
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Table 3. Mean day and night values for membrane characteristics
Normals
(N = 6)
MC
(N = 2)
MN
(N = 4)
FGS/MCGN
(N = 2)
All patients(N = 8)
Day
Small pore A
Large pore A
45
70
46
75
47
80
44.0
75
43.0
75
44
75
445e
75
Surface large pores % 4.78 9.09 9.70 17.15 11.32"
Shunt w 0 0.00064 0.00287 0.00322 0.00240
Shunt w >< GFR; mi/mm 0 0.050 0.366 0.222 0.236
SSE/pp 0.093 0.041 0.053 0.054 0.027 0.045 0.039
Night
Small pore A
Large pore A
46.5
75
44.0
75
42.8
75
43
75
43.le
75
Surface large pores % 5.42 7.18 8.42 11.69 8.93a
Shunt co 0 0.00044 0.00069 0.00180 0.00087"
Shunt co >< GFR; mi/mm 0 0.0310 0.0667 0.088 0.063"
SSEIpp 0.028 0.042 0.099 0.129 0.082"
radius was lower in the normals than in the patients (P < 0.05;
Fig. 1).
All normal subjects had a circadian rhythm for the clearance of
inulin with a mean orthophase at 16.50 hours and a mean AIM of
40% (Table 4). Renal clearance of dextran fractions 30 to 65 A
also showed circadian rhythms with a similar orthophase and A/M
as the rhythm in inulin clearance, which implied that fractional
clearances of dextrans up to 65 A were constant around the clock
and did not show a circadian rhythm.
Albumin clearance showed a significant circadian rhythm in five
of the six normals. The mean AIM was of similar magnitude as in
the patients, but higher (P < 0.01) than for the clearance of
neutral dextran molecules of the same Einstein-Stokes radius
(Table 4). The serum concentrations of albumin and total protein
showed a small, but significant rhythm in all subjects with a
relative amplitude of 10.3 5.4% and an orthophase at 16.50
2.15 hours.
Patients
Five patients had a more or less normal GFR ( 95 ml/min)
and three a decreased GFR (62 to 75 mi/mm; Table 1). The mean
value for the whole group was 96.0 29.4 ml/min. All patients had
a circadian rhythm in GFR (inulin clearance) with a similar
orthophase and mean A/M as found in normals (Table 5).
Renal clearances of dextran fractions (32 to 85 A) also showed
circadian rhythms with the same orthophase as the GFR rhythm
and up to 45 A also the same A/M as inulin (Table 5). For larger
dextrans the AIM was higher than the AIM of inulin clearance
(P < 0.01) and also increased with the molecular radius of the
fraction (Table 5). By implication fractional clearances of dextran
36 A and 43 A were the same during day and night (Fig. 2).
Fractional clearances of dextrans with a larger radius showed
differences between day and night, and significant circadian
rhythms were demonstrated (Fig. 2). This rhythm in "size selec-
tive" restriction of glomerular transport was "in phase" with the
rhythm in GFR, that is, restriction was highest during the night at
the nadir of GFR and lowest during the day at the peak of GFR.
The percentual difference in restriction between day and night
(AIM of the rhythm) increased with the radius of the filtered
macromolecule (r = 0.98; P < 0.001; Fig. 2).
The mean renal clearances and fractional clearances of the
serum proteins albumin, transferrin, IgG and a2-macroglobulin
were lower than for the dextran fractions of postulated similar
size, that is, 36, 43, 55 and 85 A (Fig. 1). The clearance of these
proteins showed circadian rhythms with orthophases, correspond-
ing in time with the rhythms in inulin and dextran clearance. The
relative amplitudes of the rhythms were higher and increased with
the size of the protein (Table 5). There were no significant
differences between day and night in serum concentrations of
proteins, when all patients were taken into account.
Day-night differences in the characteristics of the glomerular
barrier
Although normal subjects showed significant differences be-
tween day and night in GFR, FF, serum protein concentration and
in Kf (or P, Table 2), fractional clearances of dextrans up to 68
A appeared to be constant around the clock, and no differences
were found between day and night in the size of r1 or in the
percentage of filtration surface occupied by r2 (Table 3), which
means that the computer fits of day and night were virtually
identical.
Patients with nephrotic syndrome showed significant differences
between day and night in membrane characteristics. In daytime
the shunt pathway (co) was larger (P < 0.01) and also the large
pores took a greater percentage (P < 0.02) of the filtration surface
than during the night (Table 3; Fig. 3). When we calculated the
total quantity of filtrate passing through larger pores and shunt
pathway (co), it was 11.0 3.3 mi/mm during the day and 6.9 3.2
ml/min (= 63% of the daytime quantity; P < 0.02) during the
night. Expressed as fraction of total GFR these data were 11.6
4.6% in daytime versus 9.0 3.5% during the night (P < 0.02).
Abbreviations are: MC, minimal change nephropathy; MN, membranous nephropathy; FGS, focal glomerular sclerosis; MCGN,
proliferative glomerulonephritis; SSE/pp, error of the fit.
aP < 0.05 night versus day
"P < 0.01 night versus day
P < 0.05 patients versus normals
d P < 0.01 patients versus normals
mesangiocapillary
1246 Koopman et al: Circadian rhythm in macromolecular transport
0.1
0.01
Table 5. Relative amplitudes and orthophases (mean SD) of
circadian rhythms in clearances of dextrans and proteins in patients
with glomerular disease
AT
Relative amplitudes % Orthophases hr
Dextrans Proteins Dextrans Proteins
Inulin 35.1 14.0 14.44 4.74
36 A
43 A
40.6 28.3
46.6 26.2
100.5 40.8'
98.1 41.1
15.37 4.22
15.37 4.22
14.81 2.71
15.50 2.09
55 A 61.4 334h 122.3 445ac 15.37 4.22 15.31 2.34
65 A
75 A
76.3 46.7"
100.6 602h
13.87 3.37
13.87 3.37
13.25 2.75
85 A 127.2 68.2" 147.8 347d 13.87 337
IgG â
0.001
0.0001 dsA
'P < 0.01 protein vs. dextran
hp < 0.01 vs. inulin and dextran 36—43 A
P < 0.05 vs. albumin and transferrindP < 0.01 vs. albumin and transferrin, P < 0.05 vs. IgG
Fractional clearances
(I)
ci)0C
cci
ci)0
cciC0
0
cci
C
cci
I)
35404448525660646872768084 90A
Einstein-Stokes radius
Fig. 1. Mean fractional clearance (y-axis) of dextrans (—) and proteins
(-- -) in nephrotic patients (•,A) and normals (0, A) versus the Einstein-
Stokes radius (x-axis). Abbreviations are: A, albumin; T, transferrin; a2m, u2-
macroglobulin.
Table 4. Relative amplitudes and orthophases (mean sn) of
circadian rhythms in clearances of dextrans and albumin in normals
Night Day
2124 3 6 9 12 15 18 21 Clockhours
cc2M A
120
100
80
120
100
80
Dextran 36 A
Dextran 43 A1I
120
100
cci 80
-Co 120
o 100
80
1
Dextran 55 A
Dextran 65 A
Relative amplitudes % Orthophases hr
Dextrans Proteins Dextrans Proteins
Inulin 40.3 15.2 16.50 03.29
36 A 38.1 14.8 97.7 59.8 17.25 01.25 15.90 02.27
43 A 35.6 20.2 17.50 01.80
55 A 34.6 09.2 18.00 02.30
65 A 48.5 28.1 18.00 01.89
120
100 Dextran 75 A
80
140
100 Dextran 85 A
60
Fig. 2. Percentual change relative to the mean fractional clearance, calcu-
lated eveiy three hours for dextrans with increasing molecular radius in
patients with nephrotic syndrome. Data are expressed as mean SEM.
percentage of filtration surface occupied by large pores (r2). On
the average, the small pore (r,) appeared to be smaller in patients
than in normals (P < 0.05; Table 3). Kf was much lower (P < 0.01)
in patients than in healthy persons, and also in patients with a
normal GFR, even when we used a P of 35 mm Hg for the
When only transport through the shunt pathway (w) was taken
into account the day-night differences were even more pronounced.
The quantity of filtrate passing through the shunt pathway decreased
from 0.24 0.22 mI/mm during the day to 0.06 0.04 mI/mm (=
27% of the daytime quantity) during the night (P < 0.01). The size
of the small pores (r,) did not change over the 24 hours.
When patients with nephrotic syndrome were compared with
normal subjects, not only a shunt pathway was obligatory to make
a better fit, but for this purpose we also needed a larger
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calculation (Table 2). The lowest Kf values were observed in
nephrotic patients with impaired GFR and a non-selective pro-
teinuria (Table 3). When L.P was assumed constant, the percen-
tual decrease in I( during the night was less pronounced in
patients (to 79% of the daytime value) than in the normals (to
60% of the daytime value; P < 0.01). When the I(f was kept
constant around the clock, AP decreased to 87% of the daytime
value in normals and to 88% of the daytime value in patients (P>
0.05).
Discussion
In this study we demonstrated that, in patients with nephrotic
syndrome, a circadian rhythm in size-selective restriction of
glomerular transport is present, and the relative amplitude of this
rhythm increases with the radius of the dextran macromolecule
that passes through the glomerular membrane. To be discussed is
the mechanism of this rhythm and its contribution to the circadian
variability in proteinuria [2, 3] and in the selectivity index of
proteinuria [2, 3].
All healthy individuals had a circadian rhythm in GFR with an
orthophase in daytime and a relative amplitude in the expected
range [1, 4, 5]. Renal clearances of dextrans in the range of 30 to
65 A followed circadian rhythms with the same phase and
amplitude as the rhythm in GFR, which implicated that fractional
clearances of these dextrans were constant around the clock.
Thus, in normals with an intact barrier function we did not find
any evidence for a rhythm in size-selective restriction of glomer-
ular transport for macromolecules. This means that the higher
relative amplitude of the albumin clearance rhythm (97%) in
comparison with the dextran 36 A clearance rhythm (38%) might
be due to day-night variations in charge selective restriction of
glomerular transport and/or in fractional tubular reabsorption.
Evidence for circadian variability in both processes has been
presented by us in previous studies [6, 16]. A third possibility is the
difference between dextrans and proteins in three dimensional
molecular structure. This could imply that dextrans behave like
smaller molecules, or proteins like larger molecules, than one
would expect from their molecular radius [17].
In patients with nephrotic syndrome, fractional clearances of
dextrans larger than 45 A were higher than in normals. In a plot
of fractional clearance against molecular radius on semilogarith-
mic scale the decrease was also less steep than in normals and
appeared to level off in the higher range. Measurements could be
performed up to a radius of 85 to 90 A. These findings indicate
increased size-dependent permeability and the presence of more
and wider large pore pathways.
All patients had a circadian rhythm in GFR and thus probably
in K1 or z.P. Mean orthophase and relative amplitude were in
accordance with previous observations [1, 4, 5]. Clearances of
dextrans smaller than 45 A showed a circadian rhythm with the
same phase and relative amplitude as the GFR rhythm, which
means that fractional clearances did not vary between day and
night. Clearances of dextrans larger than 45 A also followed
circadian rhythms with the same phase as the rhythm in inulin
clearance. In contrast, the relative amplitude was higher and
increased with the size of the macromolecules. Thus, in glomer-
ular disease with malfunction or lesions in the glomerular barrier,
a rhythm in size-selective restriction of glomerular transport for
larger macromolecules becomes present. Restriction appeared to
be highest at night at the nadir of the GFR rhythm. The strong
phase relationship between the rhythms in fractional clearances of
large dextrans and the rhythm in GFR suggests that dynamic
changes in, for instance, K1 or zP might act as "inductors" of the
rhythmic changes in size-selective restriction.
In this and in previous studies [2, 3] renal clearance of the very
large protein a2-macroglobulin showed a circadian rhythm with a
higher A/M than the rhythm in clearance of the smaller IgG
protein; in turn, this rhythm had a higher amplitude than the
rhythms in clearance of the even smaller proteins albumin and
transferrin. A similar relationship between AiM of the rhythm
in clearance and molecular size was demonstrated for dextrans in
this study. In our opinion the observed day-night differences in
size-selective permeability of the glomerular membrane, superim-
posed on the circadian variations in GFR (that is, K1 and/or P),
are responsible for the higher amplitude in clearance rhythm for
larger macromolecules in comparison with the smaller ones. It can
also explain the previously found circadian rhythm in selectivity
index of proteinuria [2, 3]. Yet unresolved is why circadian
rhythms in the clearance of (smaller) proteins like albumin,
transferrin and IgG have higher relative amplitudes than the
rhythms in clearance of dextrans of the same Einstein-Stokes
radius. Similar to that discussed in normals, the additional per-
centage of rhythmicity can be due to circadian variations in
charge-dependent restriction of glomerular filtration (especially
of albumin and transferrin) and/or in fractional tubular reabsorp-
tion of the proteins. Differences in circadian behavior between
proteins and dextrans due to a different three-dimensional struc-
ture of the molecules is another very good possibility for the
difference in NM. The hypothesis is that dextrans are more easily
deformable than the globally structured proteins, and thus can
elongate their shape while passing through the glomerular barrier
[17]. Therefore, they behave in fact like smaller macromolecules
than their Einstein-Stokes radius suggests. If, for instance, albu-
min and transferrin would behave, in respect to size-selective
restriction of their glomerular transport, like dextran 75 A and
IgG like dextran 85 A, we would not need additional circadian
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Fig. 3. Mean fractional clearance (y axis) of dextrans in patients with
nephrotic syndrome at the orthophase of the GFR rhythm (day, 0) and at the
nadir of the GFR rhythm (night, •). The dotted line connects the
experimental data; the drawn line is the computer fit.
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variability in charge-selective filtration or fractional tubular reab-
sorption to explain the relative amplitude of the circadian rhythm
in the clearance of these proteins.
Models for analysis of sieving curves have already been used by
many groups [12—15, 18, 191. Provided that an accurate fit can be
made, the advantage is that one obtains a more objective way to
compare sieving profiles. It can be measured in what part of the
curve differences occur, either between various glomerular dis-
eases or between patients or before and after drug interventions.
A disadvantage is that in humans some assumptions must be
made, because zP cannot be measured and invasive diagnostic
methods would be needed to measure actual renal plasma flow or
oncotic pressure.
Most study groups assumed the glomerular barrier to be a
heteroporous membrane, consisting of a population of small cylin-
drical pores of equal size and a population of very large pores, that
act indiscriminately to the filtration process. The last population is
also indicated as a shunt pathway or 0) [7, 14, 15, 191. When dex-
tran 40 is administered, dextran clearances up to 60A can be
measured. These sieving curves usually fit quite well in this model.
We used a mixture of dextran 40 and 70 and, therefore, could
determine clearances up to 85 to 90A in patients with nephrotic
syndrome. Our sieving curves did not fit properly in this "one pore
size plus shunt" model. As mentioned in the Methods section and
illustrated in Figure 3, the best fit can probably be obtained with
a model using a log normal distribution of pores [12, 13, 18, 20] as
a true "shunt pathway," that is, a true horizontal part in the
sieving curve, was often not reached, especially not during the
night. Unfortunately, a log normal distribution model was not at
our disposal. We chose "second best," that is, a model using in
fact three populations of pores: (1) a small pore (r1) which could
vary in size; (2) a large pore (r2) with a fixed size of 75A, which
could vary in number (% filtration surface, occupied by r2); and
(3) a very large indiscriminative pore or shunt pathway (w)
population. To obtain the best fit, the last population had to be
zero in normal glomeruli, but in patients, even in those with
minimal change disease, the fit of the curves was better including
rather than excluding this very wide pore or shunt population.
A morphological substrate for these pore populations cannot
be given. However, it is obvious from our observations that the
quantity of large and very large pores, participating in the
filtration process of macromolecules, increases when more ad-
vanced glomerular lesions are present. The size of the small pores
in our model was similar to the size of the peak pores in the log
normal distribution model in glomerular diseases. Also in accor-
dance with this model was the finding that less than 1% of
glomerular filtrate passed through pores larger than 75 to 80A [12,
18, 20].
When we analyzed circadian variations in size-selective prop-
erties of the glomerular barrier in our filtration model, the size of
the small pore (r1) and the percentage of filtration surface
occupied by large pores (r2) appeared to be constant around the
clock in normal volunteers, although a distinct circadian rhythm
was present in GFR and thus probably in Kf and/or zP. In
contrast, in patients with nephrotic syndrome remarkable varia-
tions were found in the membrane characteristics. The most
important percentual difference between day and night in the
patients appeared to be the quantity of filtrate passing trough the
very large pores or shunt pathway (w X GFR). During the night
only a quarter of the daytime amount passed through the shunt.
Also significantly different was the contribution of the hypothe-
sized large pore of 75 A to glomerular filtration. During the day a
higher percentage of filtration surface with large pores was
involved in the filtration process than during the night. On the
average, transport at night through large pores and shunt together
was reduced to 65% of the daytime quantity.
The day-night difference in passage of filtrate through the shunt
pathway was the largest in the four patients with membranous
nephropathy, normal GFR and moderately selective proteinuria.
In patients with reduced GFR and non-selective proteinuria, who
were supposed to suffer from more structural glomerular damage,
nocturnal transport of filtrate passing through the large pores and
the shunt was less reduced, although it was still significantly lower
than during the day. These patients also had the highest percent-
age of larger pores contributing to the filtration surface. Finally, in
the patients with minimal change nephropathy the participation of
a shunt pathway and a population of large pores in glomerular
filtration was the smallest, although still higher than in normal
glomeruli. In our study we did not observe any differences in size
of the small pore between day and night.
What actually could be the mechanism of a day-night difference
in glomerular transport through large and very large pores
remains speculative. As mentioned before, the mechanism must
be dynamic, that is, easily reversible and reinducable, and in time
related to the variations in GFR. As shown in Table 2 and
reported by us earlier [1, 4], renal plasma flow and filtration
fraction also show circadian rhythms with a peak during the day
and through at night, although often a few hours shifted compared
to the peak and nadir of GFR. One could hypothesize that
distribution of plasma flow c.q. blood flow within the kidney
and/or within glomeruli fluctuates rhythmically over the 24 hours
as well. This could result in different pore populations and
numbers of pores participating in the filtration process of large
macromolecules during the night than during the day. Variation in
the actual size of large pores seems, in our opinion, far more
unlikely to be circadian, but cannot be totally excluded either.
In conclusion, patients with functional or structural lesions of
the glomerular barrier, but a reasonably preserved GFR, show
circadian variability in size-selective restriction of glomerular
transport of dextran macromolecules larger than 45 A. This
rhythm appears to bear a phase-relationship with circadian
rhythms in glomerular hemodynamic parameters and is probably
induced by them. The amplitude of the rhythm increases with the
radius of the transported macromolecules. This rhythmicity in
fractional clearance of large dextrans through large and very large
pores (shunt pathway) probably is the basis for the previously
found relationship between the molecular weight of a protein and
the relative amplitude of the rhythm in renal clearance and for the
circadian variability in selectivity index of proteinuria.
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